Prospective observational study on safety of intraperitoneal access port system in intraperitoneal chemotherapy for gastric cancer

Prospective observational study on safety of intraperitoneal access port system in intraperitoneal chemotherapy for gastric cancer - Obeseravational study on safety of intraperitoneal access port system

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000021370

Enrollment

Registered

2016-03-07

Start date

2014-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)age ranged between 20 and 75 years old 2)histologically or cytologically proven peritoneal dissemination of gastric cancer 3)peritoneal dissemination with unresectable or recurrent gastric adenocarcinoma 4)performance status (Eastern Cooperative Oncology Group) of 0 to 2 5)an expected survival period of>3 months 6)adequate organ function 7)ability to oral intake 8)written infromed consent

Exclusion criteria

Exclusion criteria: 1)no uncontrolled infection 2)no unsuitable body type for peritoenal accesss prot 3)no allergy for material of peritoneal access port 4)no unsuitalbe skin or subctaneous tissue trouble for peritoneal acesss port. 5)no severe complication 6)no uncontrolled pleural or cardiac effusion 7)no symptomatic brain metastasis 8)no other concurrent malignancies 9)no interstitial pneumoniae or pulmonary fibrosis 10)no pregnant 11)no massive ascites

Design outcomes

Primary

Measure	Time frame
adverse events	—

Countries

Japan

Contacts

Public ContactJun Kinoshita

Kanazawa University Gastroenterlogic surgery

junkino0416@gmail.com011-81-76-265-2362

Outcome results